Pierpaolo Mastroiacovo

Pierpaolo Mastroiacovo

Auto-generated profile, based on publicly available information

Pierpaolo Mastroiacovo

Alessandra Lisi International Centre on Birth Defects and Prematurity, Via Carlo Mirabello 14, Rome, 00195, Italy

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 February 2005 in BMJ
Verified
Journal Article
Open access
PDF file
LBLorenzo D Botto
Lorenzo D Botto
ALAlessandra Lisi
Alessandra Lisi
ERElisabeth Robert-Gnansia
Elisabeth Robert-Gnansia
JEJ David Erickson
J David Erickson
SVStein Emil Vollset
Stein Emil Vollset
JGJanine Goujard
Janine Goujard
Objectives To evaluate the effectiveness of policies and recommendations on folic acid aimed at reducing the occurrence of neural tube defects. Design Retrospective cohort study of births monitored by birth defect registries. Setting 13 birth defects registries monitoring rates of neural tube defects from 1988 to 1998 in Norway, Finland, Northern Netherlands, England and Wales, Ireland, France (Paris, Strasbourg, and Central East), Hungary, Italy (Emilia Romagna and Campania), Portugal, and Israel. Cases of neural tube defects were ascertained among liveborn infants, stillbirths, and pregnancy terminations (where legal). Policies and recommendations were ascertained by interview and literature review. Main outcome measures Incidences and trends in rates of neural tube defects before and after 1992 (the year of the first recommendations) and before and after the year of local recommendations (when applicable). Results The issuing of recommendations on folic acid was followed by no detectable improvement in the trends of incidence of neural tube defects. Conclusions Recommendations alone did not seem to influence trends in neural tube defects up to six years after the confirmation of the effectiveness of folic acid in clinical trials. New cases of neural tube defects preventable by folic acid continue to accumulate. A reasonable strategy would be to quickly integrate food fortification with fuller implementation of recommendations on supplements.

1 November 2000 in Epilepsia
Verified
Journal Article
Open access
PDF file
CACarla Arpino
Carla Arpino
SBSonia Brescianini
Sonia Brescianini
ERElisabeth Robert
Elisabeth Robert
ECEduardo E. Castilla
Eduardo E. Castilla
GCGuido Cocchi
Guido Cocchi
PMPierpaolo Mastroiacovo
Pierpaolo Mastroiacovo
Summary: Purpose: The study goal was to assess teratogenic effects of antiepileptic drugs (AEDs) through the use of a surveillance system (MADRE) of infants with malformations. Methods: Information on all malformed infants (1990–1996) with maternal first‐trimester drug exposure was collected by the International Clearinghouse for Birth Defects and Monitoring Systems (ICBDMS). Cases were defined as infants presenting with a specific malformation, and controls were defined as infants presenting with any other birth defect. Exposure was defined by the use of AEDs during the first trimester of pregnancy. The association of AEDs with malformations was then estimated by calculating the odds ratios with 95% confidence intervals and testing their homogeneity among registries. Results: Among 8005 cases of malformations, 299 infants were exposed in utero to AEDs. Of those exposed to monotherapy, 65 were exposed to phenobarbital, 10 to methylphenobarbital, 80 to valproic acid, 46 to carbamazepine, 24 to phenytoin, and 16 to other AEDs. Associations were found for spina bifida with valproic acid. Infants exposed to phenobarbital and to methylphenobarbital showed an increased risk of oral clefts. Cardiac malformations were found to be associated with phenobarbital, methylphenobarbital, valproic acid, and carbamazepine. Hypospadias was associated with valproic acid. Porencephaly and other specified anomalies of brain, anomalies of face, coarctation of aorta, and limb reduction defects were found to be associated with valproic acid. Conclusions: Using the MADRE system, we confirmed known teratogenic effects of AEDs. We also found increased risks for malformations that had never been reported associated with AEDs or for which the association was suggested by case reports.

13 March 2007 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
PMPierpaolo Mastroiacovo
Pierpaolo Mastroiacovo
ALAlessandra Lisi
Alessandra Lisi
ECEduardo E. Castilla
Eduardo E. Castilla
MMMaría‐Luisa Martínez‐Frías
María‐Luisa Martínez‐Frías
EBEva Bermejo-Sánchez
Eva Bermejo-Sánchez
LYLyubov Yevtushok
Lyubov Yevtushok

6 October 2006 in Birth Defects Research Part A: Clinical and Molecular Teratology
Verified
Journal Article
Closed access
PDF file
LBLorenzo D. Botto
Lorenzo D. Botto
ALAlessandra Lisi
Alessandra Lisi
CBCarol Bower
Carol Bower
MCMark A. Canfield
Mark A. Canfield
NDNirupa Dattani
Nirupa Dattani
PMPierpaolo Mastroiacovo
Pierpaolo Mastroiacovo

16 February 2006 in BMJ
Verified
Journal Article
Closed access
PMPierpaolo Mastroiacovo
Pierpaolo Mastroiacovo
ALAlessandra Lisi
Alessandra Lisi
ECEduardo E Castilla
Eduardo E Castilla
EDITOR—Kilby says that gastroschisis shows an increasing temporal trend in the number of affected babies born in the United Kingdom,1 a trend that has also been observed in other parts of the world.2 We evaluated the data of 25 registries of members of the International Clearinghouse for Birth Defects …

14 December 2002 in BMJ
Verified
Journal Article
Closed access
GTGian Luca Di Tanna
Gian Luca Di Tanna
ARAldo Rosano
Aldo Rosano
PMPierpaolo Mastroiacovo
Pierpaolo Mastroiacovo
We selected registries that provided information on at least 10 consecutive years including 1998 and analysed births occurring between 1974 and 1998 from 19 registries (see bmj.com). The numerators of the prevalences (see table) include liveborn and stillborn babies with gastroschisis (isolated or associated with other defects); denominators are the total numbers of births. Registries used their own diagnostic criteria and definitions of gastroschisis and omphalocele, but we found no substantial differences.